IL2 and neoplasm: In HSC4-bearing huNOG-FcγR−/− mice, nivolumab induced both infiltration of T cells into tumor and increases of T-cell subpopulations expressing various cytokines or cytotoxic molecules, which include GZMB, IL-2, or IFN-γ.